Neogenomics IncChange company Symbol lookupSelect an option...NEO Neogenomics IncFCX Freeport-McMoRan IncXBIO Xenetic Biosciences IncTBCPW Thunder Bridge Capital Partners III Equity Warrant Exp 01 Feb 2025 *W EXP 02/01/2025HGKGY Power Assets Holdings LtdICPT Intercept Pharmaceuticals IncKEY KeyCorpTTWO Take-Two Interactive Software IncTOPS Top Ships IncBOLT Bolt Biotherapeutics IncGo
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories. The Company operates through two segments: Clinical Services, and Advanced Diagnostics. The Clinical Services segment provides various clinical-testing services related to oncology diagnostics, community-based oncology and pathology sales, patient engagement, and clinical decision support. The Clinical Services segment also offers Trapelo, a decision-making informatics tool, to help health care professionals navigate the rapidly evolving field of precision medicine. The Advanced Diagnostics segment includes pharma services, informatics, research and development, and minimal residual disease, liquid biopsy and therapy selection business development. Additional offerings within the Advanced Diagnostics portfolio include Informatics, which involves the licensing of de-identified data to pharmaceutical and biotech customers in the form of either retrospective records or prospective deliveries of data.
|
|
|
|
| |
Upcoming Events
Past Earnings
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
| Date | Event description | Earnings per share actual | Earnings estimate range | Previous year's actual |
|---|---|---|---|---|
| August 8, 2023 | Q2 2023 Earnings Release | -$0.05 | -$0.15 to -$0.08 | -$0.16 |
| May 8, 2023 | Q1 2023 Earnings Release | -$0.09 | -$0.27 to -$0.06 | -$0.20 |
| February 23, 2023 | Q4 2022 Earnings Release | -$0.06 | -$0.27 to -$0.10 | -$0.14 |
| November 8, 2022 | Q3 2022 Earnings Release | -$0.14 | -$0.25 to -$0.15 | -$0.08 |
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
, , , Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.